Most targeted anticancer therapies fail due to drug resistance evolution. Here we show that tumor evolution can be reproducibly redirected to engineer therapeutic opportunity, regardless of the exact ...
This study aims to establish a thyristor-controlled series compensator (TCSC) equipped with a proportional integral derivative with filter (PIDF) controller by using a futuristic optimisation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results